Picture of Genprex logo

GNPX — Genprex News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Genprex Inc expected to post a loss of $3.93 a share - Earnings Preview

* Genprex Inc  GNPX.OQ   GNPX.O  is expected to show no
change in
quarterly revenue when it reports  results on March 31
(estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Genprex Inc is for a
loss of
$3.93 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Genprex Inc
is
$165.00​, above​ its last closing price of $2.98. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -4.40       -4.40      -5.20     Missed  -18.2
 Jun. 30 2023              -4.80      -6.00     Missed  -25
 Mar. 31 2023  -4.80       -4.80      -7.60     Missed  -58.3​
 Dec. 31 2022  -5.20       -5.60      -6.00     Missed  -7.1
 ​​Sep.        -4.80       -4.80      -5.20     Missed  -8.3
 30 2022                                                
 Jun. 30 2022              -4.80      -4.40     Beat    8.3​
 Mar. 31 2022  -4.80       -4.80      -4.80     Met     0
 Dec. 31 2021  -3.20       -3.80      -4.80     Missed  -26.3
 This summary was machine generated March 29 at 19:07 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Genprex

See all news